Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.

Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.

Item
http://www.wikidata.org/entity/Q36019515
The potential of venetoclax (ABT-199) in chronic lymphocytic leukemiaHigh-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cellsCell cycle proteins as promising targets in cancer therapySmall Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.Overview of CDK9 as a target in cancer research.Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia.Potential Use of Flavopiridol in Treatment of Chronic Diseases.Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice.Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition.Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents.Cell cycle regulation and anticancer drug discovery.The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells.Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia.
P2860

Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.

Item
http://www.wikidata.org/entity/Q36019515
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@ast
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@en
type
label
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@ast
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@en
prefLabel
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@ast
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P304
P31
P356
10.1016/J.LEUKRES.2015.02.001
P433
P478
P50
P577
P698
P921
P932